8 Stocks Under $10 Making Big Moves Higher

As part of your daily routine as an active trader or investor, it's important to track the stocks in the market that are making the biggest percentage gains and the biggest percentage losses.

Stocks that are making large moves to the upside are favorites among short-term traders who want to capture some of that massive volatility. Stocks that are making big-percentage moves are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

DS Healthcare Group

  • Thursday's Range: $1.24-$1.64
  • 52-Week Range: $0.72-$4.96
  • Thursday's Volume: 434,000
  • Three-Month Average Volume: 88,193

DS Healthcare Group  (DSKX)  engages in the discovery and development of drug therapies for specialty pharmaceuticals; and commercialization of personal care products for its consumer brands in North America and internationally. This stock closed up 18.1% to $1.50 in Thursday's trading session.

From a technical perspective, DS Healthcare Group exploded higher on Thursday with monster upside volume flows. This high-volume move to the upside briefly pushed this stock back above its 20-day moving average of $1.57 a share, before it closed just below that level at $1.50 a share. Shares of DS Healthcare Group are now quickly trending within range of triggering a major breakout trade above some key overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $1.65 to around $1.75 a share with high volume.

Traders should now look for long-biased trades in DS Healthcare Group as long as it's trending above Thursday's intraday low of $1.25 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 88,193 shares. If that breakout develops soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $1.97 to its 50-day moving average of $2.08, or even $2.50 to its 200-day moving average of $2.78 a share.

Fate Therapeutics

  • Thursday's Range: $1.50-$1.71
  • 52-Week Range: $1.46-$8.78
  • Thursday's Volume: 947,000
  • Three-Month Average Volume: 256,289

Fate Therapeutics  (FATE) , a clinical-stage biopharmaceutical company, discovers and develops programmed cellular therapeutics for the treatment of severe, life-threatening diseases. This stock traded up 11.9% to $1.69 in Thursday's trading session.

From a technical perspective, Fate Therapeutics ripped sharply higher on Thursday right above its new 52-week low of $1.46 a share with strong upside volume flows. This stock has been downtrending badly over the last six months, with shares collapsing off its high of around $7 a share to its new 52-week low of $1.46 a share. During that downtrend, shares of Fate Therapeutics have been consistently making lower highs and lower lows, which is bearish technical price action. That said, this high-volume rip higher on Thursday is now quickly pushing this stock within range of triggering a big breakout trade. That trade will trigger if this stock manages to take out Thursday's intraday high of $1.71 to its 20-day moving average of $1.78 a share with high volume.

Traders should now look for long-biased trades in Fate Therapeutics as long as it's trending above its new 52-week low of $1.46 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 256,289 shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at around $1.90 to $2, or even $2.20 to its 50-day moving average of $2.54 a share.

Oncothyreon

  • Thursday's Range: $0.95-$1.06
  • 52-Week Range: $0.90-$4.69
  • Thursday's Volume: 1.41 million
  • Three-Month Average Volume: 1.21 million

Oncothyreon  (ONTY) , a clinical-stage biopharmaceutical company, engages in the research and development of therapeutic products for the treatment of cancer. This stock traded up 9.6% to $1.03 in Thursday's trading session.

From a technical perspective, Oncothyreon ripped sharply higher on Thursday right above its new 52-week low of 90 cents per share with above-average volume. This stock has been downtrending badly over the last three months, with shares collapsing off its high of $3.75 to its new 52-week low of 90 cents per share. During that downtrend, this stock has been consistently making lower highs and lower lows, which is bearish technical price action. That said, this high-volume spike to the upside is now quickly pushing shares of Oncothyreon within range of triggering a big breakout trade above some key overhead resistance levels. That trade will trigger if this stock manages to take out Thursday's intraday high of $1.06 to $1.10 a share and then once it clears its 20-day moving average of $1.11 a share with high volume.

Traders should now look for long-biased trades in Oncothyreon as long as it's trending above its new 52-week low of 90 cents per share and then once it sustains a move or close above those breakout levels with volume that hits near or above 1.21 million shares. If that breakout develops soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at around $1.25 to $1.28, or even $1.50 to its 50-day moving average of $1.61 a share.

Nexvet Biopharma

  • Thursday's Range: $3.02-$3.30
  • 52-Week Range: $2.85-$11.30
  • Thursday's Volume: 114,000
  • Three-Month Average Volume: 50,384

Nexvet Biopharma  (NVET) , a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel, species-specific biologics based on human biologics for companion animals. This stock traded up 6.8% to $3.26 in Thursday's trading session.

From a technical perspective, Nexvet Biopharma spiked sharply higher on Thursday right off some near-term support at $3 a share and back above its 20-day moving average of $3.33 a share with strong upside volume flows. This stock has been attempting to carve out a major bottoming pattern over the last three months, with shares finding buying interest multiple times around $2.85 to $3 a share. Shares of Nexvet Biopharma are now starting to rip higher off those big support levels, and it's quickly trending within range of triggering a big breakout trade. That trade will trigger if this stock manages to take out its 50-day moving average of $3.33 to $3.49 and then above more resistance at $3.60 to $3.71 a share with high volume.

Traders should now look for long-biased trades in Nexvet Biopharma as long as it's trending above some key near-term support levels at $2.90 or $2.85 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 50,384 shares. If that breakout takes hold soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $4 to $4.14, or even its 200-day moving average of $4.30 to $4.50 a share.

Sirius XM Holdings

  • Thursday's Range: $3.61-$3.71
  • 52-Week Range: $3.29-$4.20
  • Thursday's Volume: 31.20 million
  • Three-Month Average Volume: 31.18 million

Sirius XM Holdings  (SIRI)  provides satellite radio services in the U.S. This stock traded up 2.5% to $3.69 in Thursday's trading session.

From a technical perspective, Sirius XM Holdings jumped notably higher on Thursday right above its 20-day moving average of $3.54 a share with decent upside volume flows. This stock has been uptrending over the last few weeks, with shares ripping higher off its low of $3.29 to its recent high of $3.72 a share. During that uptrend, this stock has been making mostly higher lows and higher highs, which is bullish technical price action. This spike to the upside on Thursday is now quickly pushing shares of Sirius XM Holdings within range of triggering a near-term breakout trade. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $3.72 to its 50-day moving average of $3.74 and then above more resistance at $3.77 to its 200-day moving average of $3.87 a share with high volume.

Traders should now look for long-biased trades in Sirius XM Holdings as long as it's trending above its 20-day moving average of $3.54 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 31.18 million shares. If that breakout materializes soon, then this stock will set up to re-test or possibly take out is next major overhead resistance levels at $4 to $4.12, or even its 52-week high of $4.20 a share.

Encana

  • Thursday's Range: $3.57-$3.85
  • 52-Week Range: $3.00-$14.73
  • Thursday's Volume: 21.25 million
  • Three-Month Average Volume: 16.90 million


Encana
  (ECA) , engages in the development, exploration, productionand marketing of natural gas, oil, and natural gas liquids in Canada and the U.S. This stock traded up 1.9% to $3.75 in Thursday's trading session.

From a technical perspective, Encana trended modestly higher on Thursday right above some near-term support at $3.50 a share with strong upside volume flows. This stock has been attempting to carve out a major bottoming chart pattern over the last month and change, with shares finding some buying interest at $3.25 to $3 a share. Shares of Encana are now starting to rip higher above those support levels, and it's quickly moving within range of triggering a big breakout trade above some key overhead resistance levels. That trade will trigger if this stock manages to take out its 20-day moving average of $3.84 a share and then above more resistance levels at $3.85 to $4.04 a share with high volume.

Traders should now look for long-biased trades in Encana as long as it's trending above some near-term support at $3.50 or above its new 52-week low of $3 a share and then once it sustains a move or close above those breakout levels with volume that hits near or above 16.90 million shares. If that breakout kicks off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at its 50-day moving average of $4.30 to $4.50, or even $5 to around $5.50 a share.

Marathon Oil

  • Thursday's Range: $6.96-$7.42
  • 52-Week Range: $6.47-$31.53
  • Thursday's Volume: 20.78 million
  • Three-Month Average Volume: 22.13 million

Marathon Oil  (MRO)  operates as an energy company. This stock traded up 2.3% to $7.39 in Thursday's trading session.

From a technical perspective, Marathon Oil spiked modestly higher here right above its new 52-week low of $6.47 a share with decent upside volume flows. This trend to the upside on Thursday is now quickly pushing shares of Marathon Oil within range of triggering a major breakout trade above some key overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $7.50 to $7.84 a share and then above its 20-day moving average of $7.91 a share with high volume.

Traders should now look for long-biased trades in Marathon Oil as long as it's trending above Thursday's intraday low of $6.96 a share or above its new 52-week low of $6.47 a share and then once it sustains a move or close above those breakout levels with volume that registers near or above 22.13 million shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $9 to its 50-day moving average of $9.77, or even $10.21 to $10.55 a share.

SeaDrill

  • Thursday's Range: $1.73-$1.87
  • 52-Week Range: $1.57-$15.44
  • Thursday's Volume: 9.19 million
  • Three-Month Average Volume: 9.25 million

SeaDrill  (SDRL) , an offshore drilling contractor, provides offshore drilling services to the oil and gas industry worldwide. This stock traded flat to $1.82 in Thursday's trading session.

From a technical perspective, SeaDrill traded flat and closed at $1.82 a share on Thursday with decent upside volume flows. This stock has been attempting to carve out a major bottoming chart pattern over the last month and change, with shares finding some buying interest at $1.60 to $1.57 a share. This stock has now started to trend higher off those support levels and it's beginning to test its 20-day moving average of $1.85 a share. This move is quickly pushing shares of SeaDrill within range of triggering a major breakout trade above some key overhead resistance levels. That trade will trigger if this stock manages to take out some near-term overhead resistance levels at $1.87 to $1.94 a share and then above more resistance at $2 a share with high volume.

Traders should now look for long-biased trades in SeaDrill as long as it's trending above those major bottom support levels and then once it sustains a move or close above those breakout levels with volume that registers near or above 9.25 million shares. If that breakout fires off soon, then this stock will set up to re-test or possibly take out its next major overhead resistance levels at $2.23 to $2.27, or even its 50-day moving average of $2.56 a share.

Disclosure: This article is commentary by an independent contributor. At the time of publication, the author was long DSKX.

More from Opinion

Flashback Friday: Johnson & Johnson Hits Take Historic Plunge

Flashback Friday: Johnson & Johnson Hits Take Historic Plunge

Adobe's Decline After Earnings Reflects a More Risk-Averse Market

Adobe's Decline After Earnings Reflects a More Risk-Averse Market

Throwback Thursday: GE, GM Head in Opposite Directions

Throwback Thursday: GE, GM Head in Opposite Directions

Tech Reviews Aren't Always a Good Predictor of Demand (See: Apple's iPhone XR)

Tech Reviews Aren't Always a Good Predictor of Demand (See: Apple's iPhone XR)

Wednesday Wrap-Up: Roku Rebounds, Tesla Ships

Wednesday Wrap-Up: Roku Rebounds, Tesla Ships